WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2004032942) DRY ORAL PHLEBOTONIC AND VASCULOPROTECTIVE FORMULATION FOR THE TREATMENT OF VENOUS INSUFFICIENCY, CAPILLARY FRAGILITY AND HAEMORRHOIDS, IN THE PHARMACEUTICAL FORM OF A CHEWABLE TABLET CONTAINING DIOSMIN
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2004/032942    International Application No.:    PCT/FR2003/002973
Publication Date: 22.04.2004 International Filing Date: 09.10.2003
IPC:
A61K 9/00 (2006.01), A61K 9/20 (2006.01), A61K 31/7048 (2006.01)
Applicants: LABORATOIRES INNOTHERA SAS [FR/FR]; 7-9, avenue François Vincent Raspail, F-94110 Arceuil (FR) (For All Designated States Except US).
MEIGNANT, Catherine [FR/FR]; (FR) (For US Only).
VIEILLARD-BARON, Corinne [FR/FR]; (FR) (For US Only)
Inventors: MEIGNANT, Catherine; (FR).
VIEILLARD-BARON, Corinne; (FR)
Agent: DUPUIS-LATOUR, Dominique; SEP Pagenberg & Associés, 14, boulevard Malesherbes, F-75008 Paris (FR)
Priority Data:
02/12633 11.10.2002 FR
Title (EN) DRY ORAL PHLEBOTONIC AND VASCULOPROTECTIVE FORMULATION FOR THE TREATMENT OF VENOUS INSUFFICIENCY, CAPILLARY FRAGILITY AND HAEMORRHOIDS, IN THE PHARMACEUTICAL FORM OF A CHEWABLE TABLET CONTAINING DIOSMIN
(FR) FORMULATION ORALE SECHE A VISEE PHLEBOTONIQUE ET VASCULOPROTECTRICE POUR LE TRAITEMENT DE L'INSUFFISANCE VEINEUSE, DE LA FRAGILITE CAPILLAIRE ET DE LA CRISE HEMORROIDAIRE, SOUS FORME PHARMACEUTIQUE DE COMPRIME A CROQUER CONTENANT DE LA DIOSMINE
Abstract: front page image
(EN)The invention relates to a dry oral phlebtonic and vasculoprotective formulation for the treatment of venous insufficiency, capillary fragility and haemorrhoids, which takes the pharmaceutical form of a chewable tablet containing diosmin. The inventive formulation comprises a mixture of at least one active ingredient containing granular or pure diosmin and a combination of excipients. Said formulation takes the pharmaceutical form of a tablet which can be bitten, chewed or sucked. The aforementioned excipients can comprise at least two polyols, such as xylitol and sorbitol, as well as a compression agent, such as dicalcium phosphate.
(FR)Cette formulation comprend, en mélange, au moins un principe actif con­tenant de la diosmine, native ou granulée, et une combinaison d'excipi­ents. La forme pharmaceutique est celle d'un comprimé à croquer, à su­cer ou à macher. Les excipients peuvent comprendre au moins deux po­Iyols tels que le xylitol et le sorbitol, ainsi qu'un agent de compression tel que le phosphate dicalcique.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, OM, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: French (FR)
Filing Language: French (FR)